Skip to main content
FinSpry Logo
FinSpry
GRCE logo
GRCE
(NASDAQ)
Grace Therapeutics, Inc.
$5.13-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Grace Therapeutics (GRCE) Stock Price & Financial Analysis

Grace Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.70 - $5.18
52-Week High$5.05
52-Week Low$1.75
Open$4.82
Volume660.61K
Average Volume (3M)660.61K
Market Cap86.87M
Shares Outstanding16.93M
Price to Book (P/B)1.27
EV/EBITDA-5.69
50-Day MA$4.01
200-Day MA$3.39
52-Week Change115.93%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Grace Therapeutics

What is the current stock price for GRCE?

As of the latest trading session, GRCE stock trades at $5.13. The 52-week range is $1.75–$5.05, with a day range of $4.70–$5.18.

What is the P/E ratio for GRCE?

The P/E ratio (Price-to-Earnings) for GRCE is shown in the Key Statistics section. This valuation metric helps compare Grace Therapeutics, Inc. to industry peers.

Does GRCE pay dividends?

Grace Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for GRCE?

Analyst ratings and recommendations for GRCE are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of GRCE?

Grace Therapeutics's market capitalization is $86.9M, classifying it as a micro-cap company. Grace Therapeutics operates in the Healthcare sector within the Biotechnology industry.